Carolin Curtze1, John G Nutt2, Patricia Carlson-Kuhta3, Martina Mancini4, Fay B Horak5. 1. C. Curtze, PhD, Department of Neurology, School of Medicine, Oregon Health & Science University, 3181 Sam Jackson Park Rd, Portland, OR 97239-3098 (USA). curtze@ohsu.edu. 2. J.G. Nutt, MD, Department of Neurology, School of Medicine, Oregon Health & Science University. 3. P. Carlson-Kuhta, PhD, Department of Neurology, School of Medicine, Oregon Health & Science University. 4. M. Mancini, PhD, Department of Neurology, School of Medicine, Oregon Health & Science University. 5. F.B. Horak, PhD, Department of Neurology, School of Medicine, Oregon Health & Science University, and Veterans Affairs Portland Health Care System, Portland, Oregon.
Abstract
BACKGROUND: Body-worn, inertial sensors can provide many objective measures of balance and gait. However, the objective measures that best reflect patient perception of mobility disability and clinician assessment of Parkinson disease (PD) are unknown. OBJECTIVE: The purposes of this study were: (1) to determine which objective measures of balance and gait are most related to patient perception of mobility disability and disease severity in people with PD and (2) to examine the effect of levodopa therapy on these correlates. DESIGN: This was an experimental correlation study. METHODS: One hundred four people with idiopathic PD performed 3 trials of the Instrumented Stand and Walk Test (ISAW) in the "on" and "off" medication states. The ISAW consists of quiet standing (30 seconds), gait initiation, straight walking (7 m), and turning (180°), yielding 34 objective measures of mobility from body-worn inertial sensors. Patient perception of mobility disability was assessed with the Activities-specific Balance Confidence (ABC) scale and the mobility subscale of the Parkinson's Disease Questionnaire (PDQ-39). Disease severity was assessed with the Unified Parkinson's Disease Rating Scale, part III (motor UPDRS). Spearman correlations were used to relate objective measures of mobility to patient perception and disease severity. RESULTS: Turning speed, gait speed, and stride length were most highly correlated to severity of disease and patient perception of mobility disability. The objective measures of mobility in the off-medication state were more indicative of patient perception of mobility disability and balance confidence compared with on-medication state measures. LIMITATIONS: Causation is an inherent problem of correlation studies. CONCLUSION: Physical therapists should evaluate mobility in people with PD in the off-medication state because the off-medication state is more related to disease severity and patient perception of mobility disability than the on-medication state mobility. Assessment and treatment of mobility in people with PD should target specific measures (ie, turning, gait speed, and stride length) because these measures best reflect patients' quality of life and balance confidence.
BACKGROUND: Body-worn, inertial sensors can provide many objective measures of balance and gait. However, the objective measures that best reflect patient perception of mobility disability and clinician assessment of Parkinson disease (PD) are unknown. OBJECTIVE: The purposes of this study were: (1) to determine which objective measures of balance and gait are most related to patient perception of mobility disability and disease severity in people with PD and (2) to examine the effect of levodopa therapy on these correlates. DESIGN: This was an experimental correlation study. METHODS: One hundred four people with idiopathic PD performed 3 trials of the Instrumented Stand and Walk Test (ISAW) in the "on" and "off" medication states. The ISAW consists of quiet standing (30 seconds), gait initiation, straight walking (7 m), and turning (180°), yielding 34 objective measures of mobility from body-worn inertial sensors. Patient perception of mobility disability was assessed with the Activities-specific Balance Confidence (ABC) scale and the mobility subscale of the Parkinson's Disease Questionnaire (PDQ-39). Disease severity was assessed with the Unified Parkinson's Disease Rating Scale, part III (motor UPDRS). Spearman correlations were used to relate objective measures of mobility to patient perception and disease severity. RESULTS: Turning speed, gait speed, and stride length were most highly correlated to severity of disease and patient perception of mobility disability. The objective measures of mobility in the off-medication state were more indicative of patient perception of mobility disability and balance confidence compared with on-medication state measures. LIMITATIONS: Causation is an inherent problem of correlation studies. CONCLUSION: Physical therapists should evaluate mobility in people with PD in the off-medication state because the off-medication state is more related to disease severity and patient perception of mobility disability than the on-medication state mobility. Assessment and treatment of mobility in people with PD should target specific measures (ie, turning, gait speed, and stride length) because these measures best reflect patients' quality of life and balance confidence.
Authors: Martina Mancini; Mahmoud El-Gohary; Sean Pearson; James McNames; Heather Schlueter; John G Nutt; Laurie A King; Fay B Horak Journal: NeuroRehabilitation Date: 2015 Impact factor: 2.138
Authors: L A King; A Salarian; M Mancini; K C Priest; J Nutt; A Serdar; J Wilhelm; J Schlimgen; M Smith; F B Horak Journal: Parkinsons Dis Date: 2013-04-30
Authors: Tecla Bonci; Francesca Salis; Kirsty Scott; Lisa Alcock; Clemens Becker; Stefano Bertuletti; Ellen Buckley; Marco Caruso; Andrea Cereatti; Silvia Del Din; Eran Gazit; Clint Hansen; Jeffrey M Hausdorff; Walter Maetzler; Luca Palmerini; Lynn Rochester; Lars Schwickert; Basil Sharrack; Ioannis Vogiatzis; Claudia Mazzà Journal: Front Bioeng Biotechnol Date: 2022-06-02
Authors: Kyle T Miller; Molly Russell; Terese Jenks; Kaddie Surratt; Kelly Poretti; Samantha S Eigenbrot; Jonathan S Akins; Matthew J Major Journal: J Prosthet Orthot Date: 2020-08-11